pdf

O'Melveny’s Representation of Alta Partners in Investment Covered in Multiple Media Outlets

December 05, 2012

O’Melveny & Myers LLP’s representation of Alta Partners as the lead investor in a US$21 million financing in Zafgen Inc., a biopharmaceutical company, was noted in the Daily Journal, IPFrontline, and Pharmalive.com. Proceeds from the financing will be used to develop an obesity-fighting drug, according to the reporters. O’Melveny’s Silicon Valley-based team was led by partner Sam Zucker and counsel Jeff Cislini.